Investec Bank Plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure identifies Investec as an exempt principal trader acting in a client-serving capacity with recognised intermediary status under the Code.
Investec confirmed its role as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connection to the offer party named in the filing.
The dealings were undertaken on 1st October 2026, with the formal disclosure filed on 2nd October 2026 in accordance with regulatory requirements.
On the purchase side, Investec Bank Plc acquired 75,151 ordinary shares in Advanced Medical Solutions Group Plc during the dealing period.
The highest price paid per unit on purchases was 282.02 pence, while the lowest price paid per unit came in at 282 pence.
On the sell side, Investec disposed of 56,486 ordinary shares, with prices ranging from a high of 282.5 pence to a low of 282.25 pence per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed that no indemnity arrangements, option agreements, or understandings relating to relevant securities were in place that could constitute an inducement to deal or refrain from dealing.
The bank also stated that no agreements or understandings existed relating to voting rights under any option or future acquisition and disposal of relevant securities tied to any derivative instrument.
The contact named in the disclosure is Priyali Bhattacharjee, reachable by telephone in connection with queries relating to this filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service, ensuring full market transparency during offer periods.
